We show that in invasive breast carcinomas, CRIP1 expression is associated with not only HER2 expression but also the metastases-free survival of patients, with a more favorable prognosis for patients with high CRIP1 expression. The gene discussed is ERBB2; the disease is invasive breast carcinoma.